Assuntos
Doenças do Desenvolvimento Ósseo/diagnóstico por imagem , Encéfalo/anormalidades , Aberrações Cromossômicas , Cromossomos Humanos Par 14/genética , Anormalidades Congênitas/genética , Diagnóstico Pré-Natal/métodos , Adulto , Doenças do Desenvolvimento Ósseo/embriologia , Doenças do Desenvolvimento Ósseo/genética , Encéfalo/diagnóstico por imagem , Encéfalo/embriologia , Consanguinidade , Feminino , Humanos , Masculino , Paquistão/etnologia , Gravidez , Análise Serial de Tecidos , Ultrassonografia Pré-NatalRESUMO
While ELISA is a frequently used means of assessing 8-oxo-7,8-dihydro-2-deoxyguanosine (8-oxodG) in biological fluids, differences in baseline urinary 8-oxodG levels, compared to chromatographic techniques, have raised questions regarding the specificity of immunoassays. Recently, ELISA of salivary 8-oxodG has been used to report on periodontal disease. We compared salivary 8-oxodG levels, determined by two commercial ELISA kits, to liquid chromatography-tandem mass spectrometry (LC-MS/MS) with prior purification using solid-phase extraction. While values were obtained with both ELISA kits, salivary 8-oxodG values were below or around the limit of detection of our LC-MS/MS assay. As the limit of detection for the LC-MS/MS procedure is much lower than ELISA, we concluded that the assessment of salivary 8-oxodG by ELISA is not accurate. In contrast to previous studies, ELISA levels of urinary 8-oxodG (1.67 +/- 0.53 pmol/mumol creatinine) were within the range reported previously only for chromatographic assays, although still significantly different than LC-MS/MS (0.41 +/- 0.39 pmol/mumol creatinine; p = 0.002). Furthermore, no correlation with LC-MS/MS was seen. These results question the ability of ELISA approaches, at present, to specifically determine absolute levels of 8-oxodG in saliva and urine. Ongoing investigation in our laboratories aims to identify the basis of the discrepancy between ELISA and LC-MS/MS.
